Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab

PURPOSE: Trastuzumab, a humanized anti-human epidermal growth factor receptor 2 (anti-HER2) antibody delivered intravenously, has revolutionized the treatment of patients with breast cancer overexpressing HER2 protein. Recently, a newer subcutaneous formulation was shown to have comparable efficacy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer (Auckl)
Autors principals: Syrios, John, Pappa, Evelina, Volakakis, Nikolaos, Grivas, Anastasios, Alafis, John, Manioudaki, Sofia, Tzouda, Vasiliki, Korogiannos, Athanasios, Rapti, Cleopatra, Koufopoulos, Nektarios, Nikolaidou, Adamantia, Kanavou, Eleftheria, Alexopoulos, Athanasios, Koumarianou, Anna
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5826003/
https://ncbi.nlm.nih.gov/pubmed/29511355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1178223418758031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars